Pfizer Enters China's GLP-1 Market with Xianweiying Pre-Orders, Intensifies Weight-Loss Drug Race Written By sheeba farhat26 April 2026 9:30 AM ISTNew Delhi: Pfizer's GLP-1 weight management treatment Xianweiying is available for pre-order in China, a Reuters check on a local e-commerce...
Roche Q1 Sales Dip 5% on Currency Headwinds, Pins Hopes on New Drugs, Weight-Loss Entry Written By sheeba farhat25 April 2026 5:06 PM ISTNew Delhi: Swiss drugmaker Roche's first-quarter sales dropped by 5%, it said on Thursday, citing unfavourable foreign exchange effects that offset...
AI Meets Pharma: Novo Nordisk Teams Up with OpenAI for Faster Drug Innovation Written By sheeba farhat15 April 2026 7:00 PM ISTNew Delhi: Danish pharmaceuticals group Novo Nordisk, maker of the popular Ozempic and Wegovy anti-obesity drugs, announced Tuesday a "strategic...
Oral Weight-Loss Pills Gain Ground as Patients Prefer Cheaper, Needle-Free Options Over Injections Written By sheeba farhat7 April 2026 10:00 AM ISTWashington: Americans starting weight-loss medicines for the first time want lower cost and greater convenience as they consider pills from Novo...
Roche Aims to Build Affordable, Tolerable Obesity Drug Portfolio: Genentech CEO Written By sheeba farhat17 March 2026 6:00 PM ISTNew York: Roche's Ashley Magargee, chief executive of its Genentech unit, said on Monday the company is striving to build a portfolio of obesity...
Novo Nordisk Loses USD 50 Billion as Obesity Drug Price War Triggers Profit, Sales Warning Written By sheeba farhat6 Feb 2026 11:15 AM ISTNew Delhi: Novo Nordisk's shares tumbled on Wednesday, knocking nearly USD 50 billion in value from the Danish obesity drug giant, as it warned that...
Novo Nordisk Tie-Up, Strong Growth Lift Emcure Pharma Q3 Profit 48% to Rs 231 Cr Written By sheeba farhat5 Feb 2026 4:29 PM ISTEmcure reported a Profit After Tax (PAT) of Rs 156 crore for the October-December period of last fiscal.
Eli Lilly Announces USD 3.5 Billion US Manufacturing Facility for Next-Gen Obesity Drugs Written By sheeba farhat31 Jan 2026 5:27 PM ISTNew Delhi: Eli Lilly announced on Friday that it will build a pharmaceutical manufacturing facility in Pennsylvania, its fourth new site in an effort...
No Link to Suicidal Thoughts: USFDA Seeks Label Change for Popular Weight-Loss Drugs Wegovy, Zepbound Written By sheeba farhat14 Jan 2026 6:57 PM ISTThe warnings, part of their original approval, were based on reports of such events observed with a variety of older medicines used or studied for...
Novo Nordisk Projects Oral Weight-Loss Pills to Take One-Third of GLP-1 Market by 2030 Written By sheeba farhat13 Jan 2026 5:23 PM ISTNovo launched a daily oral version of Wegovy in the U.S. earlier this month with a starting cash price of USD 149 per month.
Eli Lilly Expands Immunology Pipeline with USD 1.2 Billion Ventyx Buyout Written By sheeba farhat9 Jan 2026 2:53 PM ISTThis is Lilly's first major transaction of 2026, following a year when its market value topped USD 1 trillion on surging sales of GLP-1 drugs...
Novo Nordisk's US Public Affairs Head Jennifer Duck Exits Amid Pricing Pressure, Obesity Drug Battle Written By sheeba farhat7 Jan 2026 4:04 PM ISTCEO Doustdar is trying to restore investor confidence by sharpening Novo's focus, after a tough year in which the company issued multiple profit...
